Cure Parkinson’s
19 results.
Grand Rapids, Mich. (Sept. 25, 2024) — Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce
GRAND RAPIDS (Mich.) Sept. 29, 2023 — Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr. Natasha Fothergill-Misbah, Research…
Copenhagen, Denmark (August 28, 2023) — A one-year, phase 2 clinical trial of Type 2 diabetes drug lixisenatide has reported positive early results, which indicate…
Grand Rapids, Mich. (March 13, 2023) — Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce that their co-funding agreement, which supports…
Drug repurposing program seeks to find treatments that slow or stop Parkinson’s progression and serve as a roadmap for similar initiatives in other diseases Could…
GRAND RAPIDS, Mich. (June 15, 2020) — For the first time, Grand Challenges in Parkinson’s Disease and Rallying to the Challenge, Van Andel Institute’s flagship…
NOTE: This release was originally published by The Cure Parkinson’s Trust LONDON (Feb. 13, 2020) — The Cure Parkinson’s Trust (CPT) and Van Andel Institute…
NOTE: This release was originally published by The Cure Parkinson’s Trust. Results published today in the Journal of the American Medical Association (JAMA)…